Abstract
Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing NS5A inhibitors with sofosbuvir/velpatasvir plus ribavirin for 24 weeks
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have